Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01608308 · ClinicalTrials.gov registry record · NA

Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery

A NA study of Chronic Sinusitis, sponsored by The University of Texas Health Science Center, Houston.

Completed
Registry status
NA
Development phase
62
Enrollment target
1
Study location

NCT01608308 is a NA study of Chronic Sinusitis that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 62 participants, below the 189-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01608308, a NA study of Chronic Sinusitis, has completed, sponsored by The University of Texas Health Science Center, Houston.

COMPLETED
Registry status
NA
Development phase
62 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess the use of IV acetaminophen (Ofirmev) as a and safe and efficacious agent in reducing post-operative pain; we hypothesize that its use will reduce post-operative pain when compared to a control group using the visual analogue score (VAS) analog pain scoring system.

Conditions Studied

Interventions

  • DRUG Placebo
  • DRUG IV Acetaminophen

Study Locations (1)

Texas

  • The University of Texas Health Sciences Center at Houston - Houston

Trial Details

FieldValue
Enrollment Target 62 participants
Start Date 2012-07
Est. Completion 2014-09
Phase NA

What the Registry Record Tells You About NCT01608308

The ClinicalTrials.gov registry entry for NCT01608308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 189-participant average among 9 other Chronic Sinusitis trials with a reported enrollment target (67% lower). The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Chronic Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT01608308 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT01608308 about?

NCT01608308 is a clinical study titled "Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery". The purpose of this study is to assess the use of IV acetaminophen (Ofirmev) as a and safe and efficacious agent in reducing post-operative pain; we hypothesize that its use will reduce post-operative pain when compared to a control group using the visual analogue score (VAS) analog pain scoring sys...

What is the current status of trial NCT01608308?

This trial is currently completed. It is a NA study. The enrollment target is 62 participants. The study started on 2012-07. Estimated completion is 2014-09.

What conditions does trial NCT01608308 study?

This clinical trial studies the following conditions: Chronic Sinusitis.

What interventions are being tested in trial NCT01608308?

The interventions under investigation include: Placebo (DRUG), IV Acetaminophen (DRUG).

Who is sponsoring clinical trial NCT01608308?

This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01608308 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Sinusitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.